• We are pioneering world-first treatments, including gene therapy, nanotechnology and stem cells.
• UCL Partnership hospitals treated 810,000 patients in 2011, more than a third of all London hospital visits.
• We have helped our partners implement a new cross-sector model of care for stroke that has reduced mortality to below 10% in north central London, against a 22% national average.

• UCL is ranked second in the world, and first in Europe, in neuroscience and behaviour research.
• UCL is placed third in Europe and seventh in the world for clinical, pre-clinical and health research.
• The Thomson Scientific Citation Index shows that UCL is the second most highly cited European university and 14th in the world.

• 2nd highest allocation of grants from the Medical Research Council
• 5th highest allocation from the Biotechnology and Biological Sciences Research Council
• 2nd biggest university recipient of UK government medical research funding
• £84 million from charities.

• Faculty of Medical Sciences: £53.7m
• Faculty of Brain Sciences: £61.5 m
• Faculty of Life Sciences: £21.7m
• Faculty of Population Health Sciences: £60.1m

UCL has dedicated research institutes working hand-in-hand with prestigious partner hospitals in London. These centres of excellence benefit from wider alliances such as UCL Partners and the transatlantic Yale-UCL collaborative.